Distinguished University Professor
Professor, Department of Psychiatry and Behavioral Sciences
Director, Center for Drug & Alcohol Programs
Director, Clinical Neurobiology Laboratory |
EDUCATION | Rutgers College, New Brunswick, NJ | B.A. | 1972 | Biosciences | | Rutgers School of Medicine, New Brunswick, NJ | M.D. | 1976 | Medicine | | Greenwich Hospital, Greenwich, CT | Internship | 1977 | Medicine | | Yale New Haven Hospital & Connecticut Mental Health Center, New Haven, CT | Residency | 1980 | Psychiatry | | Yale University School of Medicine, New Haven, CT | Postdoctoral | 1980 | Psychiatry |
PROFESSIONAL EXPERIENCE | 1980-1985 | Assistant Professor, Department of Psychiatry & Behavioral Sciences, MUSC, Charleston, SC | | 1980-1988 | Staff Psychiatrist, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC | | 1984-1988 | Director, Psychopharmacology Research, Veterans Affairs Medical Center, Charleston, SC | | 1985-1991 | Associate Professor, Department of Psychiatry & Behavioral Sciences, MUSC, Charleston, SC | | 1988-present | Director, Clinical-Neurobiology Laboratories, Department of Psychiatry & Behavioral Sciences, MUSC, Charleston, SC | | 1991-present | Professor, Department of Psychiatry & Behavioral Sciences, MUSC, Charleston, SC | | 1993-2001 | Director, Alcohol Medication Studies, Center for Drug and Alcohol Programs, MUSC, Charleston, SC | | 1995-present | Scientific Director for Clinical Research, Charleston Alcohol Research Center, MUSC, Charleston, SC | | 2001-present | Director, Center for Drug and Alcohol Programs, MUSC, Charleston, SC | | 2002-present | Distinguished University Professor, MUSC, Charleston, SC |
AWARDS AND HONORS
| 1991 | NIAAA Alcohol Psychosocial Research Review Committee (Member Clinical & Treatment Subcommittee; Chair, 1993-1994) | | 1992 | NIAAA Working Group on Methodology in Clinical Treatment Research Trials | | 1992 | NIAAA Task Force on Revision of the Treatment Assessment Manual | | 1996 | American College of Neuropsychopharmacology (elected member) | | 1997 | American Society of Addiction Medicine (diplomat) | | 1997 | Added Qualifications in Addiction Psychiatry | | 1999 | Board of Directors, Research Society on Alcoholism | | 1999-2002 | Board of Scientific Counselors of the National Institute of Alcohol Abuse and Alcoholism | | 2000-present | Member, Board of reviewing Editors, Alcoholism: Clinical and Experimental Research | | 2000-present | Chairman, Steering Committee, COMBINE Study | | 2001 | Treasurer, Research Society on Alcoholism | | 2003 | American College of Neuropsychopharmacology (elected fellow) | | 2005 | Vice-Chairman, Board of Trustees, Alcohol Beverage Medical Research Foundation | | 2007-2008 | President, Research Society on Alcoholism | | 2008 | Distinguished Fellow, American Psychiatric Association |
RECENT PUBLICATIONS
Anton RF. Genetic basis for predicting response to naltrexone in the treatment of alcohol dependence. Pharmacogenomics 9(6):655-658, 2008.
Anton RF. Naltrexone for the management of alcohol dependence. New England Journal of Medicine 359(7):715-721, 2008. NIHMSID: NIHMS67847, PMCID: PMC2565602 Anton RF, Kranzler H, Breder C, Marcus RN, Carson WH & Han J. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence. Journal of Clinical Psychopharmacology 28(1):5-12, 2008.
Anton RF, Oroszi G, O'Malley S, Couper D, Swift R, Pettinati H & Goldman D. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Archives of General Psychiatry 65(2):135-144, 2008.
Baros AM, Latham PK & Anton RF. Naltrexone and cognitive behavioral therapy for the treatment of alcohol dependence: Do sex differences exist? Alcoholism: Clinical & Experimental Research 32(5):771-776, 2008. NIHMSID: NIHMS65293, PMCID: PMC2553698
Baros AM, Wright TM, Latham PK, Miller PM & Anton RF. Alcohol consumption, %CDT, GGT and blood pressure change during alcohol treatment. Alcohol & Alcoholism 43(2):192-197, 2008.
Covault J, Gelernter J, Jensen K, Anton R & Kranzler HR. Markers in the 5'-region of GABRG1 associate to alcohol dependence and are in linkage disequilibrium with markers in the adjacent GABRA2 gene. Neuropsychopharmacology 33(4):837-848, 2008.
Donovan DM, Anton RF, Miller WR, Longabaugh R, Hosking JD, Youngblood M & Combine Study Research Group. Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): Examination of posttreatment drinking outcomes. Journal of Studies on Alcohol 69(1):5-13, 2008.
Jeppsson JO, Arndt T, Schellenberg F, Wielders JP, Anton RF, Whitfield JB & Helander A. Standardization of carbohydrate-deficient transferrin: Reply to the letter by Tagliaro and Bortolotti. Clinical Chemistry and Laboratory Medicine 46(5):727-728, 2008.
Johnson BA, Ait-Daoud N, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O'Malley SS & Swift RM. Topiramate as treatment for alcohol dependence-Reply. Journal of the American Medical Association 299(4):406-407, 2008.
Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Addolorato G, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O'Malley SS, Swift RM, Topiramate for Alcoholism Advisory Board & Topiramate for Alcoholism Study Group. Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Archives of Internal Medicine 168(11):1188-1199, 2008.
Luo X, Zuo L, Kranzler HR, Wang S, Anton RF & Gelernter J. Recessive genetic mode of an ADH4 variant in substance dependence in African-Americans: A model of utility of the HWD test. Behavioral and Brain Functions 4:42, 2008. PMCID: PMC2563013
Myrick H, Anton RF, Li X, Henderson S, Randall PK & Voronin K. Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Archives of General Psychiatry 65(4):466-475, 2008. NIHMSID: NIHMS55593, PMCID: PMC2504413
Stewart SH, Latham PK, Miller PM, Randall P & Anton RF. Blood pressure reduction during treatment for alcohol dependence: Results from the Combining Medications and Behavioral Interventions for Alcoholism (COMBINE) study. Addiction 103(10):1622-1628, 2008. NIHMSID: NIHMS85866.
Voronin K, Randall P, Myrick H & Anton R. Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm - Possible influence of self-control. Alcoholism: Clinical & Experimental Research 32(11):1954-1961, 2008. NIHMSID: NIHMS64368, PMCID: PMC2588475
Farrer, L.A., Kranzler, H.R., Yu, Y., Weiss, R.D., Brady, K.T., Anton, R., Cubells, J.F., Gelernter, J. Association of variants in MANEA with cocaine-related behaviors. Archives of General Psychiatry 66(3):267-274, 2009. Stewart SH, Oroszi G, Randall PK & Anton RF. COMT genotype influences the effect of alcohol on blood pressure: Results from the COMBINE study. American Journal of Hypertension 22(1):87-91, 2009. NIHMSID: NIHMS85665 |
